Order Jalupro® 2x30 mg/3mL + 2x100 mg for Clinics

Jalupro® 2×30 mg/3mL + 2×100 mg is a professional injectable dermal biorevitalization kit combining sodium hyaluronate solution with lyophilized amino acids. Licensed clinics, med spas, and healthcare professionals can order the kit for intradermal skin-quality protocols that require measured vials, sterile handling, and predictable treatment-room preparation. The format includes two sodium hyaluronate vials and two amino acid ampoules mixed immediately before administration.

Med Wholesale Supplies serves licensed medical and aesthetic practices with brand-name clinic supplies sourced through vetted distributors and verified supply channels. This presentation is used in professional workflows focused on hydration support, dermal texture, and the appearance of fine lines, with US distribution supporting inventory planning for scheduled treatment days.

Price, Kit Selection, and Clinic Ordering

Clinics can buy Jalupro 2x30mg/3ml + 2x100mg online by signing in to a professional account and selecting the quantity needed for upcoming sessions. Current Jalupro 2x30mg 3ml + 2x100mg price details are shown during ordering, including account-specific or volume-based purchasing information when applicable. The kit size is useful for practices that plan skin booster appointments, staged rejuvenation protocols, and staff training sessions around a consistent preparation format.

The product name identifies the clinic-facing pack composition: two 30 mg/3 mL sodium hyaluronate vials and two 100 mg lyophilized amino acid ampoules. Because the components are separate until use, teams should match their order quantity to planned treatment areas, appointment volume, staff availability, and storage capacity. For practices building a wider injectable skin-quality formulary, the skin boosters category provides adjacent options for protocol planning.

Quick tip: Record lot numbers and expiry dates at receiving, then stage the kit only when the treatment room is ready for preparation.

What the Jalupro® Kit Contains and How It Works

This Jalupro injectable presentation is a resorbable, sterile preparation assembled at the point of use. The sodium hyaluronate solution supplies a hydrating matrix component, while the amino acid ampoules provide glycine, L-proline, L-lysine, and L-leucine. The amino acid component is mixed with the hyaluronate immediately before intradermal placement by qualified professionals following manufacturer instructions and clinic protocols.

In aesthetic practice, sodium hyaluronate is valued for water binding and tissue hydration support. The amino acids in the kit are selected to complement dermal matrix-focused treatment plans. Biorevitalization refers to injectable skin-quality work intended to support texture, hydration, and overall dermal appearance rather than replace structural volumizing fillers.

Professional Applications in Aesthetic Workflows

Clinics commonly use Jalupro sodium hyaluronate amino acids within mesotherapy-style skin booster programs. Mesotherapy describes superficial injectable techniques used in aesthetic medicine for targeted skin-quality support. This kit can fit facial rejuvenation plans and selected body-area protocols when technique, patient assessment, and manufacturer guidance support its use.

Typical clinic areas may include the face, neck, décolletage, hands, inner thighs, abdomen, and knees. Practices may also schedule it around chemical peels, laser sessions, radiofrequency treatments, or filler programs when their clinical protocols call for tissue preparation or maintenance. For workflow context beyond a single product, the professional article on mesotherapy clinical uses, risks, and workflow can help teams align documentation, technique planning, and staff roles.

The product does not replace clinical assessment. Trained injectors should evaluate anatomy, skin quality, treatment history, active inflammation, medical history, and procedure timing before administration. Aesthetic endpoints should be documented in practice records so follow-up visits can distinguish hydration, texture, and combination-treatment effects.

Key Features for Treatment-Room Use

• Mix-on-site kit with separated hyaluronate solution and amino acid ampoules.
• Two vials of sodium hyaluronate solution, each labeled 30 mg/3 mL.
• Two ampoules of lyophilized amino acids, each labeled 100 mg.
• Designed for professional intradermal injection techniques.
• Useful in skin-quality pathways focused on hydration and texture.
• Adaptable for facial and selected body-area protocols.
• Resorbable components that are processed over time.
• Compact clinic pack format for appointment-based inventory control.

The pre-measured format helps reduce preparation variation between trained team members. It also supports cleaner inventory planning because each kit presents the active components in a clearly separated, documented configuration. Clinics should still follow internal controls for sterile field setup, sharps management, product reconciliation, and post-procedure record keeping.

Benefits in Clinic Practice

The main operational benefit is consistency. A clearly defined Jalupro kit 2×30 mg/3mL + 2×100 mg gives staff a repeatable preparation process, which helps during scheduled skin booster blocks or training days. The two-part format also allows the practice to mix only at the appropriate point in the visit rather than relying on a pre-combined preparation.

• Streamlined setup for trained injectors and assisting staff.
• Predictable kit contents for session planning and purchasing.
• Flexible use across texture, hydration, and maintenance-oriented protocols.
• Clearer documentation because lot and expiry information can be captured at kit level.
• Compatibility with staged aesthetic plans when protocols support combination care.
• Practical inventory handling for clinics that manage multiple injectable categories.

Many teams evaluate Jalupro alongside other injectable skin-quality products rather than as an isolated purchase. For a deeper discussion of mechanism and collagen-related treatment goals, the article on the science behind Jalupro gives additional educational context for professional planning.

Composition and Ingredient Notes

Each Jalupro injection 2×30 mg/3mL + 2×100 mg presentation combines sodium hyaluronate with a lyophilized amino acid blend. The amino acid portion includes glycine, L-proline, L-lysine, and L-leucine. These components are mixed according to the manufacturer’s instructions immediately before intradermal administration.

Ingredient review matters because skin booster protocols may be scheduled near other procedures, topical regimens, and injectable treatments. Clinics should document product identity, treatment area, injection technique, and any relevant patient history before proceeding. Staff should also confirm that the packaging is intact and that the kit is within expiry before preparation.

Why it matters: Separate components require disciplined preparation, but they also give clinics a defined point-of-use mixing process.

Packaging, Storage, and Handling

Jalupro vials 2×30 mg/3mL + 2×100 mg are supplied as two sodium hyaluronate vials and two lyophilized amino acid ampoules. Units should remain sealed until use, protected according to label instructions, and stored in a manner that prevents mix-ups with other injectable products. Receiving teams should inspect labeling, packaging integrity, lot numbers, and expiry dates before the kit enters active inventory.

Because the preparation is injectable and assembled shortly before treatment, aseptic technique is essential. Staff should avoid preparing the mixture before the patient is assessed and the treatment area is ready. Used sharps, opened containers, and any remaining materials should be handled according to clinical waste procedures and manufacturer directions.

We support clinic procurement with reliable US logistics, including temperature-controlled handling when required and tracked US delivery. Practices with multiple locations should set internal procedures for receiving, storage transfer, treatment-room staging, and documentation so kit traceability remains clear from purchase through administration.

Safety, Precautions, and Professional Documentation

Jalupro is intended for administration by appropriately trained healthcare professionals. As with other intradermal injectable procedures, clinics should assess for contraindications, active skin infection, inflammation at the treatment site, relevant allergy history, recent aesthetic procedures, and any factors that may increase bruising or healing concerns. Manufacturer materials and training protocols should guide technique, injection plane, spacing, and aftercare communication.

Expected injection-site effects may include temporary redness, swelling, tenderness, bruising, itching, or localized discomfort. More significant concerns can include persistent inflammation, infection, nodules, vascular compromise, or hypersensitivity reactions, depending on the product used, patient factors, and injection technique. Clinics should have escalation procedures for unusual pain, color change, prolonged swelling, signs of infection, or other concerning reactions after treatment.

Documentation should include the product name, lot number, expiry date, treatment area, volume prepared or administered when recorded by the practice, injector name, technique notes, and post-treatment instructions. This record supports audit readiness, continuity of care, and product traceability. For broader educational context on injectable hydration approaches, see skin booster injections in aesthetic practice.

Comparable Jalupro and Skin Booster Choices

Practices often compare Jalupro Classic-style amino acid kits with other Jalupro presentations based on treatment area, viscosity, patient profile, and protocol goals. Jalupro HMW may be considered when a clinic wants to evaluate a higher molecular weight HA option within the same family. Jalupro Young Eye is relevant when periocular treatment planning requires a product developed for that delicate zone.

Some practices also maintain non-injectable or adjunct Jalupro products for post-procedure support and patient-facing regimen planning. Jalupro Enhancer Gel may be reviewed as a related product in the broader brand portfolio. For product-family browsing, the Jalupro brand category keeps related presentations together for purchasing teams.

Selection should be based on clinical training, treatment area, injection depth, expected tissue response, and practice protocols. The comparison article Jalupro vs Profhilo can support internal discussion about skin booster positioning, but final product choice should follow professional judgment and manufacturer guidance.

Inventory Planning and Substitution Strategy

Clinics that run regular skin-quality appointments should plan reorder points around procedure calendars, injector schedules, and expected treatment areas. A compact kit may be easier to assign to specific sessions than bulkier inventory, but staff still need clear controls for receiving, storage, preparation, and reconciliation. Practices should avoid switching products mid-protocol without evaluating handling, injection plane, tissue goals, and patient-specific considerations.

If supply planning requires alternatives, start with the same product family or the same clinical category before moving to a different modality. The mesotherapy category can help teams review products used in superficial injectable workflows, while the skin boosters education category supports broader training discussions. Substitutions should be documented so treatment plans remain traceable and consistent across providers.

Authoritative Product Information

For exact preparation steps, contraindications, warnings, and handling requirements, consult the manufacturer package insert supplied with the kit. Clinic protocols should also reflect the injector’s training, applicable professional standards, and internal policies for sterile technique, consent, adverse-event handling, and medical record documentation.

When evaluating injectable aesthetic products, teams should rely on manufacturer instructions and recognized clinical education rather than consumer claims or informal treatment summaries. Product selection, injection technique, and procedure sequencing should remain under the direction of qualified professionals.

This content is for informational purposes only and is not a substitute for professional medical advice.